Insider Transactions in Q2 2025 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 16
2025
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,928
-10.96%
|
$109,984
$28.4 P/Share
|
Apr 16
2025
|
Kyle Jenne EVP, Chf GL Pdt Str Ofcr |
SELL
Open market or private sale
|
Direct |
3,016
-21.22%
|
$84,448
$28.36 P/Share
|
Apr 16
2025
|
Brian Birchler EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct |
680
-1.19%
|
$19,040
$28.37 P/Share
|
Apr 15
2025
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,837
+23.21%
|
-
|
Apr 15
2025
|
Kyle Jenne EVP, Chf GL Pdt Str Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
12,226
+46.24%
|
-
|
Apr 15
2025
|
Brian Birchler EVP, Corp and Development Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+3.17%
|
-
|